<DOC>
	<DOCNO>NCT02236234</DOCNO>
	<brief_summary>Besides specific response vaccine antigen , investigator analyze anti-HPV immune response HIV-1-infected men different stratum immune deficiency . The hypothesis test stratification T CD4 + lymphocytes attempt ass range count high possibility vaccine response . Thus , knowledge vaccine response HIV-infected patient , indicate patient would great potential vaccine response vivo .</brief_summary>
	<brief_title>Immune Response HPV Vaccine Among HIV-1-infected Subjects Brazil</brief_title>
	<detailed_description>The study divide three group . Patients HIV-1 infection subdivide group accord T CD4 + lymphocytes time vaccination : Over 500 CD4 T cell count bellow 500 CD4 T cell count . A healthy control group also study .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>HIV Men age 35 45 year age . Current previous infection human papillomavirus ( HPV )</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>HPV</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>outcome</keyword>
</DOC>